NDC 62756-184
Oxcarbazepine 300 mg tablet, film coated
On the label: Caraco Pharmaceutical Laboratories, Ltd..
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited | Halol, India | Makes it and tests it | Serious problems, FDA actionJun 13, 2025 · 12 inspections, 5 with FDA action |
Recalls
- Dec 1, 2022 · Class II · Sun Pharmaceutical Industries Inc
Presence of foreign substance
Lots: a) Lot HAC1474A, Expires 03/2023 b) Lot HAC1503A, Expires 03/2023 c) Lot HAC1474B, Expires 03/2023 - Jan 29, 2014 · Class II · Caraco Pharmaceutical Laboratories Ltd.
Failed Tablet Specifications: Broken Tablets Present.
Lots: Lot #: JKM7075A, Expiry:10/15
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Oxcarbazepine: every company that makes it
- Form
- tablet, film coated, oral
- Strength
- 300 mg
- Approval
- ANDA ANDA077794
- On the market since
- Oct 9, 2007
- Package NDCs
62756-184-0862756-184-1362756-184-1862756-184-8362756-184-88- Official label
- DailyMed (National Library of Medicine), updated Jun 3, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?